LoginRegister
    Lupin posts Rs 123 crore net loss in Q2Lupin posts Rs 123 crore net loss in Q2
    OxyContin maker Purdue Pharma gets interim shield from litigationOxyContin maker Purdue Pharma gets interim shield from litigation
    Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate InjectionZydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in ChinaSun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China
    Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drugNovartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug
    Japans Takeda to sell portfolio of select drugs for USD 660 millionJapan's Takeda to sell portfolio of select drugs for USD 660 million
    Biocon gets EIR from USFDA for Bengaluru biologics unitBiocon gets EIR from USFDA for Bengaluru biologics unit
    Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping systemMost Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system
    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facilityZydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility
    Medical device maker Stryker to buy Wright Medical for USD 4 BillionMedical device maker Stryker to buy Wright Medical for USD 4 Billion
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 crSun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr
    Alleged carcinogenic impurity in Ranitidine: Dr Reddys Laboratories makes Rs 40-crore provisioning in PnL for market impactAlleged carcinogenic impurity in Ranitidine: Dr Reddy's Laboratories makes Rs 40-crore provisioning...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X